Bioxytran, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.112 USD | +1.82% | +10.78% | -25.33% |
04-19 | Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Bioxytran, Inc. Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-25.33% | 19.25M | |
+3.61% | 108B | |
+11.20% | 104B | |
+1.28% | 22.33B | |
-12.69% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.47% | 17.64B | |
+3.80% | 14.05B | |
+37.58% | 12.51B |
- Stock Market
- Equities
- BIXT Stock
- News Bioxytran, Inc.
- Bioxytran, Inc. Auditor Raises 'Going Concern' Doubt